Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses
Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses. // Cancer Genetics. – URL: https://www.sciencedirect.com/science/article/pii/S221077622600075X?dgcid=rss_sd_all
Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses. Cancer Genetics. https://www.sciencedirect.com/science/article/pii/S221077622600075X?dgcid=rss_sd_all
“Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses.” Cancer Genetics.
@article{article39877,
title = {Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses},
journal = {Cancer Genetics},
url = {https://www.sciencedirect.com/science/article/pii/S221077622600075X?dgcid=rss_sd_all}
}
Oncogene, Published online: 19 November 2026; doi:10.1038/s41388-026-04055-6 Extrachromosomal circular DNA in human cancer: from biogenesis mechanisms to therapeutic vulnerabilities
Oncogene, Published online: 18 November 2026; doi:10.1038/s41388-026-04044-9 PIM kinase inhibition induces epigenetically conditioned transcriptional changes, abnormal RNA splicing and DNA damage in diffuse large B-cell lymphoma cells
Oncogene, Published online: 14 November 2026; doi:10.1038/s41388-026-04014-1 PDGF-BB and bFGF repress Kai1 in pericytes through Src–DNMT-associated promoter methylation and lysosomal trafficking
Oncogene, Published online: 13 November 2026; doi:10.1038/s41388-026-04058-3 Editorial Expression of Concern: Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey
Oncogene, Published online: 10 November 2026; doi:10.1038/s41388-026-03994-4 B3GNT9-mediated O-glycosylation reprograms fatty acid metabolism in peroxisomes to promote invasion progression of peritumoral glioma cells